Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Algra

Showing results (11-20 of 294) with videos related to

Pageof 30
Sort By:
Cerebrovascular Diseases (Basel, Switzerland)|August 7, 1999
Secondary stroke prevention with drugs: single or combined therapy?J van Gijn, A Algra
Thrombosis Research|November 1, 2003
Aspirin and stroke preventionJ van Gijn, A Algra
Lancet (London, England)|April 23, 1994
Science unblindedA Algra, J van Gijn
Nederlands Tijdschrift Voor Geneeskunde|May 14, 1994
[20,000 kg aspirin and 45 pages British Medical Journal]F R Rosendaal, A Algra
Nederlands Tijdschrift Voor Geneeskunde|August 12, 1999
[Clinical researchers and the pharmaceutical industry. Usefulness and need for an independent steering committee]J Van Gijn, A Algra
Nederlands Tijdschrift Voor Geneeskunde|March 22, 2001
[Surgery for a recently symptomatic severe carotid stenosis, indicated or not? Clinical application of 'evidence-based' medicine]W A Hoefnagels, A Algra
Journal of Neurology, Neurosurgery, and Psychiatry|December 17, 1998
Systematic review of antifibrinolytic treatment in aneurysmal subarachnoid haemorrhageY B Roos, M Vermeulen, G J Rinkel, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 13, 1999
[Roaming through methodology. XII. Pragmatic and pathophysiologic trials: a question of goal formulation]A Algra, Y van der Graaf
Nederlands Tijdschrift Voor Geneeskunde|April 18, 2002
[A new instrument to measure clinical outcomes]A Algra, G J E Rinkel
Cerebrovascular Diseases (Basel, Switzerland)|November 29, 2007
Anticoagulants, aspirin and dipyridamole in the secondary prevention of cerebral ischaemia: which is the best for which patient?P H A Halkes, A Algra
Pageof 30

Showing results (11-20 of 294) with videos related to

Sort By:
Pageof 30
Cerebrovascular Diseases (Basel, Switzerland)|August 7, 1999
Secondary stroke prevention with drugs: single or combined therapy?J van Gijn, A Algra
Thrombosis Research|November 1, 2003
Aspirin and stroke preventionJ van Gijn, A Algra
Lancet (London, England)|April 23, 1994
Science unblindedA Algra, J van Gijn
Nederlands Tijdschrift Voor Geneeskunde|May 14, 1994
[20,000 kg aspirin and 45 pages British Medical Journal]F R Rosendaal, A Algra
Nederlands Tijdschrift Voor Geneeskunde|August 12, 1999
[Clinical researchers and the pharmaceutical industry. Usefulness and need for an independent steering committee]J Van Gijn, A Algra
Nederlands Tijdschrift Voor Geneeskunde|March 22, 2001
[Surgery for a recently symptomatic severe carotid stenosis, indicated or not? Clinical application of 'evidence-based' medicine]W A Hoefnagels, A Algra
Journal of Neurology, Neurosurgery, and Psychiatry|December 17, 1998
Systematic review of antifibrinolytic treatment in aneurysmal subarachnoid haemorrhageY B Roos, M Vermeulen, G J Rinkel, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 13, 1999
[Roaming through methodology. XII. Pragmatic and pathophysiologic trials: a question of goal formulation]A Algra, Y van der Graaf
Nederlands Tijdschrift Voor Geneeskunde|April 18, 2002
[A new instrument to measure clinical outcomes]A Algra, G J E Rinkel
Cerebrovascular Diseases (Basel, Switzerland)|November 29, 2007
Anticoagulants, aspirin and dipyridamole in the secondary prevention of cerebral ischaemia: which is the best for which patient?P H A Halkes, A Algra
Pageof 30